Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241814066 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Smriti Shreya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gene Expression and Signaling Lab, Department of Zoology, Mahatma Gandhi Central University, Motihari 845401, Bihar, India. Hauptthemen laut MEDLINE: Unfolded Protein Response, Liver Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Groupama Centre-Atlantique, La Fondation Groupama pour la Santé, La Région Nouvelle-Aquitaine.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) is the site for synthesis and folding of secreted and transmembrane proteins. Disturbance in the functioning of ER leads to the accumulation of unfolded and misfolded proteins, which finally activate the unfolded protein response (UPR) signaling. The three branches of UPR—IRE1 (Inositol requiring enzyme 1), PERK (Protein kinase RNA-activated (PKR)-like ER kinase), and ATF6 (Activating transcription factor 6)—modulate the gene expression pattern through increased expression of chaperones and restore ER homeostasis by enhancing ER protein folding capacity. The liver is a central organ which performs a variety of functions which help in maintaining the overall well-being of our body. The liver plays many roles in cellular physiology, blood homeostasis, and detoxification, and is the main site at which protein synthesis occurs. Disturbance in ER homeostasis is triggered by calcium level imbalance, change in redox status, viral infection, and so on. ER dysfunction and subsequent UPR signaling participate in various hepatic disorders like metabolic (dysfunction) associated fatty liver disease, liver cancer, viral hepatitis, and cholestasis. The exact role of ER stress and UPR signaling in various liver diseases is not fully understood and needs further investigation. Targeting UPR signaling with drugs is the subject of intensive research for therapeutic use in liver diseases. The present review summarizes the role of UPR signaling in liver disorders and describes why UPR regulators are promising therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Expression and Signaling Lab, Department of Zoology, Mahatma Gandhi Central University, Motihari 845401, Bihar, India.
- MIRCADE Team, U1312, Bordeaux Institute in Oncology, BRIC, Université de Bordeaux, 146 Rue Léo Saignat, F-33000 Bordeaux, France.
ORCID-Profile: Christophe F Grosset, Buddhi Prakash Jain
Förderung
- Groupama Centre-Atlantique
- La Fondation Groupama pour la Santé
- La Région Nouvelle-Aquitaine
- Institut National du Cancer (INCa)
- Foundation for Addie's Research
- Groupama Centre-Atlantique, La Fondation Groupama pour la Santé, La Région Nouvelle-Aquitaine
- Foundation for Addie’s Research
- Aidons Marina; Aline en Lutte contre la Leucémie; Cassandra; E.S.CA.P.E.; Eva pour la Vie; Grandir sans Cancer; Les Amis de Marius; Les Récoltes de l’Espoir; N…
Zitieren
APA
Shreya, S., Grosset, C. F., & Jain, B. P. (2023). Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814066
Vancouver
Shreya S, Grosset CF, Jain BP. Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814066
BibTeX
@article{Shreya2023,
author = {Shreya, Smriti and Grosset, Christophe F and Jain, Buddhi Prakash},
title = {Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241814066}
}
EUVIMED